These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34562947)

  • 1. Distinct Methodologies to Produce Capped Mesoporous Silica with Hydroxyapatite and the Influence in Intracellular Signaling as Cytotoxicity on Human Umbilical Vein Endothelial Cells.
    da Silva de Barros AO; Rebêlo Alencar LM; Alexis F; Santos-Oliveira R
    Bioengineering (Basel); 2021 Sep; 8(9):. PubMed ID: 34562947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-synthesis and drug delivery properties of mesoporous hydroxyapatite-silica composites.
    Zhao YF; Loo SC; Ma J
    J Nanosci Nanotechnol; 2009 Jun; 9(6):3720-7. PubMed ID: 19504909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH-Sensitive Hybrid System Based on Eu
    Dos Apostolos RCR; Andrada AS; Oliveira AF; Neto ESF; de Sousa EMB
    Polymers (Basel); 2023 Jun; 15(12):. PubMed ID: 37376326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic Fe3O4@mesoporous silica composites for drug delivery and bioadsorption.
    Huang S; Li C; Cheng Z; Fan Y; Yang P; Zhang C; Yang K; Lin J
    J Colloid Interface Sci; 2012 Jun; 376(1):312-21. PubMed ID: 22444483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citric acid functionalized silane coupling versus post-grafting strategy for dual pH and saline responsive delivery of cisplatin by Fe
    Abedi M; Abolmaali SS; Abedanzadeh M; Borandeh S; Samani SM; Tamaddon AM
    Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109922. PubMed ID: 31499936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and In Vitro Characterization of Bioactive Mesoporous Silica with Doxorubicin and Metronidazole Intended for Bone Treatment and Regeneration.
    Czarnobaj K; Prokopowicz M; Sawicki W
    AAPS PharmSciTech; 2017 Nov; 18(8):3163-3171. PubMed ID: 28534298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoporous silica/apatite nanocomposite: special synthesis route to control local drug delivery.
    Sousa A; Souza KC; Sousa EM
    Acta Biomater; 2008 May; 4(3):671-9. PubMed ID: 18206431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of iron tailings to prepare high-surface area mesoporous silica materials.
    Lu C; Yang H; Wang J; Tan Q; Fu L
    Sci Total Environ; 2020 Sep; 736():139483. PubMed ID: 32473455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesoporous silica-based bioactive glasses for antibiotic-free antibacterial applications.
    Kaya S; Cresswell M; Boccaccini AR
    Mater Sci Eng C Mater Biol Appl; 2018 Feb; 83():99-107. PubMed ID: 29208293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of anti-inflammatory agent into mesoporous silica.
    Braz WR; Rocha NL; de Faria EH; Silva ML; Ciuffi KJ; Tavares DC; Furtado RA; Rocha LA; Nassar EJ
    Nanotechnology; 2016 Sep; 27(38):385103. PubMed ID: 27533108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth of hydroxyapatite in a biocompatible mesoporous ordered silica.
    Díaz A; López T; Manjarrez J; Basaldella E; Martínez-Blanes JM; Odriozola JA
    Acta Biomater; 2006 Mar; 2(2):173-9. PubMed ID: 16701875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and Characterization of Double Shell Fe
    Toubi F; Deezagi A; Singh G; Oghabian MA; Ali Fatemi SS; Arpanaei A
    Iran J Biotechnol; 2015 Mar; 13(1):1-10. PubMed ID: 28959275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in vitro characterisation of bioactive mesoporous silica microparticles for drug delivery applications.
    Prokopowicz M; Czarnobaj K; Szewczyk A; Sawicki W
    Mater Sci Eng C Mater Biol Appl; 2016 Mar; 60():7-18. PubMed ID: 26706501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and physicochemical characterization of mesoporous hydroxyapatite and its application in toothpaste formulation.
    Nikfallah A; Mohammadi A; Ahmadakhondi M; Ansari M
    Heliyon; 2023 Oct; 9(10):e20924. PubMed ID: 37876441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and optical properties of ordered mesoporous titania-silica composite thin films.
    Wang Z; Wang P; Li J; Lu Q
    J Nanosci Nanotechnol; 2009 Apr; 9(4):2574-81. PubMed ID: 19438004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity of mesoporous silica modified by amino and carboxyl groups on vascular endothelial cells.
    Zhao J; Bu DY; Zhang N; Tian DN; Ma LY; Yang HF
    Environ Toxicol; 2021 Jul; 36(7):1422-1433. PubMed ID: 33764655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic mesoporous silica nanoparticles end-capped with hydroxyapatite for pH-responsive drug release.
    Zhao CX; Yu L; Middelberg APJ
    J Mater Chem B; 2013 Oct; 1(37):4828-4833. PubMed ID: 32261164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic solid-phase extraction based on mesoporous silica-coated magnetic nanoparticles for analysis of oral antidiabetic drugs in human plasma.
    de Souza KC; Andrade GF; Vasconcelos I; de Oliveira Viana IM; Fernandes C; de Sousa EM
    Mater Sci Eng C Mater Biol Appl; 2014 Jul; 40():275-80. PubMed ID: 24857494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Mesoporous Silica Materials Loaded with Polyphenols: Caffeic Acid, Ferulic Acid and p-Coumaric Acid as Dietary Supplements for Oral Administration.
    Petrisor G; Motelica L; Ficai D; Trusca RD; Surdu VA; Voicu G; Oprea OC; Ficai A; Andronescu E
    Materials (Basel); 2022 Nov; 15(22):. PubMed ID: 36431468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastable, redispersible, small, and highly organomodified mesoporous silica nanotherapeutics.
    Lin YS; Abadeer N; Hurley KR; Haynes CL
    J Am Chem Soc; 2011 Dec; 133(50):20444-57. PubMed ID: 22050408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.